Unjha Formul. — 360° view

Unjha Formul, a company in the Pharmaceuticals industry, reported revenue of ₹4.41 crore and net profit of ₹0.51 crore for the September 2026 quarter.

Unjha Formul. (BSE: UNJHAFOR) closed at ₹27.45 on 20 Nov 2026, up 8.1% over the past year. Its market capitalisation is ₹12 crore and it trades at 72.3 times earnings.

Share price
₹27.45 (20 Nov 2026)
Market cap
₹12 Cr (20 Nov 2026)
P/E
72.33 (20 Nov 2026)
Revenue
₹4 Cr (September 2026 quarter)
Net profit
₹1 Cr (September 2026 quarter)
ROCE
27.8% (FY26)
ROE
20.1% (FY26)
Book value
₹10.1 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹36.38 / ₹17.52 (20 Nov 2026)
1-year return
8.1% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: UNJHAFOR

Incorporated in 1991, Unjha Formulations Ltd is a manufacturer and exporter of psyllium husk-based products.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.